Products for Research Use Only
RegisterLogin

NRC-2694

CAT: 0013-GTR19216840-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19216840-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR) . It has anti-cancer and anti-proliferative properties. (In Vitro) :NRC-2694 (80 ng) induce comparable inhibition of EGFR expression. (In Vivo) :NRC-2694 (10 mg/kg) regresses the tumor in mice. The maximum tolerated dose of NRC-2694 in male and female mice is 2000 mg/kg (p.o.), in toxicity studies .
CAS Number
936446-61-6
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (597.39 mM)
Smiles
COc1cc2ncnc (Nc3cccc (c3) C#C) c2cc1OCCCN1CCOCC1
Molecular Formula
C24H26N4O3
Molecular Weight
418.497
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.

Related Products

CatalogName
GTR19034986-01NRC-16
GTR19198444-01A 269A
GTR19163495-01AN-2690
GTR19201105MRS 2690
GTR19242087-01LJ-2698
GTR19170110-01MRE-269
GTR19163871-01TMP-269
GTR19160321-01MRE-269
GTR19201104-01MRS 2693 trisodium salt
GTR19258474-01Anticancer agent 269

Alternative Products

CatalogName
BA6372-5.1NRC-2694
HY-19909ANRC-2694-A
A20643-25NRC-2694 25mg
A20643-5NRC-2694 5mg
A20643-1NRC-2694 1mg
T71332-01NRC-2694 hydrochloride
MBS5813870NRC-2694 dihydrochloride
A20643-200NRC-2694 200mg
A20643-100NRC-2694 100mg
A20643-50NRC-2694 50mg

Popular Products